AGP Executive Report
Last update: 2 hours agoRegulated Market Expansion: Greenlight hit Ohio’s legal cap, adding four dispensaries plus in-state manufacturing, bringing its Ohio total to eight shops and expanding its broader footprint. Medical Cannabis Pipeline: SciSparc’s NeuroThera started a Phase IIb trial site at Hannover Medical School for SCI-110, a cannabinoid-based treatment candidate for adult Tourette Syndrome. Federal Policy Shift: The U.S. reclassification of cannabis (moving medical cannabis and FDA-approved cannabis items to Schedule 3) is being framed by industry as a path to clearer oversight and faster beverage/consumer innovation. Compliance & Enforcement: Virginia launched a public tip line and online form for suspected violations of its new recreational cannabis law, including illegal sales, unlicensed activity, and counterfeit products. International Business Moves: Curaleaf opened a new Florida dispensary in Edgewater, pushing its Florida count to 74 locations. Global Legal Signals: Kenya’s court dismissed a Rastafari petition seeking cannabis legalization, while urging a broader national drug policy debate. Product/Consumer Watch: A report on “Jelly Force Gummies” flags transparency gaps and urges buyers to scrutinize ingredients, pricing, and refund terms before purchasing.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
